Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2010
11/04/2010WO2010078419A3 Herbal-based nasal solution and method of use thereof
11/04/2010WO2010077061A3 Pharmaceutical formulations containing antiviral drugs
11/04/2010WO2010075444A3 Nasal formulations of metoclopramide
11/04/2010WO2010052466A3 Pharmaceutical aerosol composition
11/04/2010WO2010044097A3 Novel dosage form of paliperidone and process for preparing the same
11/04/2010WO2009135854A3 Encapsulation of biologically active agents
11/04/2010WO2009129210A4 Compositions and methods for treating post-operative pain using clonidine and bupivacaine
11/04/2010WO2009121997A3 Pegylated nanoparticles containing a biologically active molecule and use thereof
11/04/2010WO2009120919A3 Fenofibrate dosage forms
11/04/2010US20100280601 Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof
11/04/2010US20100280452 Medical devices having multiple layers
11/04/2010US20100280282 Phosphatidyl oligoglycerols
11/04/2010US20100280122 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
11/04/2010US20100280113 Compositions and methods for the treatment of cystic fibrosis
11/04/2010US20100280106 Oral composition to reduce cold symptoms and duration of same
11/04/2010US20100280055 Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions
11/04/2010US20100280035 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier
11/04/2010US20100279106 Products comprising nano-precision engineered electronic components
11/04/2010US20100278997 Preparation for restenosis prevention
11/04/2010US20100278932 Polymer micelles containing sn-38 for the treatment of cancer
11/04/2010US20100278931 Porous silicon drug-eluting particles
11/04/2010US20100278930 Oral cavity disintegrating tablet and method of producing the same
11/04/2010US20100278929 Antibody formulations having optimized aggregation and fragmentation profiles
11/04/2010US20100278928 Polymer micelles containing anthracylines for the treatment of cancer
11/04/2010US20100278927 Polymeric micelles for polynucleotide encapsulation
11/04/2010US20100278926 Controlled Release Oral Dosage Form
11/04/2010US20100278925 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof
11/04/2010US20100278924 Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
11/04/2010US20100278923 Functional nanoparticle-based antibiotics and preparation method thereof
11/04/2010US20100278922 Methods and compositions for oral administration of insulin
11/04/2010US20100278921 Solid oral formulation of abt-263
11/04/2010US20100278920 Polyacrylate Nanoparticle Drug Delivery
11/04/2010US20100278919 Dendritic cell targeting compositions and uses thereof
11/04/2010US20100278918 Extended release formulation of nevirapine
11/04/2010US20100278917 Formulations and Methods of Treating Inflammatory Bowel Disease
11/04/2010US20100278916 Topical application and formulation of erythropoietin for skin wound healing
11/04/2010US20100278915 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278913 Chewable tablet
11/04/2010US20100278912 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
11/04/2010US20100278911 Controlled release preparation
11/04/2010US20100278910 Rare earth metal compounds, methods of making, and methods of using the same
11/04/2010US20100278909 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
11/04/2010US20100278907 Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
11/04/2010US20100278906 Moisturizing antimicrobial composition
11/04/2010US20100278905 Stabilized lipid formulation of apoptosis promoter
11/04/2010US20100278904 Nucleotide vaccine
11/04/2010US20100278903 Prophylactic and immunomodulatory compositions and uses
11/04/2010US20100278902 Strontium doped bioactive glasses
11/04/2010US20100278901 Compositions and methods of making rapidly dissolving ionically masked formulations
11/04/2010US20100278900 Chlorine dioxide based gum and candy
11/04/2010US20100278899 Edible film
11/04/2010US20100278896 Solid compositions
11/04/2010US20100278895 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278894 Antioxidants and antimicrobial accessories including antioxidants
11/04/2010US20100278893 Implantable material comprising cellulose and the glycopeptide xyloglucan-grgds
11/04/2010US20100278892 High affinity metal-oxide binding peptides with reversible binding
11/04/2010US20100278887 Use of a Haemoglobin for the Preparation of Dressings and Resulting Dressings
11/04/2010US20100278886 Personal care dissolvable films
11/04/2010US20100278885 C70-Containing Liposome, Method for Producing the Same, and Use of the Same
11/04/2010US20100278883 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances
11/04/2010US20100278881 Use of calcitonin in osteoarthritis
11/04/2010US20100278880 Pharmaceutical formulation for allergen preparation
11/04/2010US20100278879 Stable pharmaceutical composition and methods of using same
11/04/2010US20100278878 Quetiapine salts and their polymorphs
11/04/2010US20100278877 Body tissue filling material and method for production thereof
11/04/2010US20100278760 Cosmetics
11/04/2010US20100278755 Composition containing p-menthane-3, 8-diol and its use as insect repellant
11/04/2010US20100278754 Orally disintegrating tablets with speckled appearance
11/04/2010US20100278744 Preparation for restenosis prevention
11/04/2010US20100278742 Methods and compositions for detection and diagnosis of infectious diseases
11/04/2010US20100278734 Nanoparticle contrast agents for diagnostic imaging
11/04/2010US20100275913 Composition for inhalation
11/04/2010US20100275502 Rodenticide
11/04/2010DE202009008622U1 Microbrausetabletten Micro effervescent tablets
11/04/2010DE19549825B4 Zuckerfreie Hartkaramellen Sugar-free hard candies
11/04/2010CA2777479A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
11/04/2010CA2760615A1 Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
11/04/2010CA2760614A1 Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs
11/04/2010CA2760590A1 Intraocular bioactive agent delivery composition including a molecular partitioning system
11/04/2010CA2760460A1 Formulations of cannabidiol and methods of using the same
11/04/2010CA2760195A1 A pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppressive action of aggressive agents on the skin
11/04/2010CA2760186A1 Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
11/04/2010CA2760128A1 Cannabinoid-containing compositions and methods for their use
11/04/2010CA2760085A1 Oral formulations of bendamustine
11/04/2010CA2760073A1 Solid preparation
11/04/2010CA2760039A1 Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof
11/04/2010CA2759984A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
11/04/2010CA2759888A1 Composition for the treatment of prostate cancer
11/04/2010CA2759284A1 Stable pharmaceutical composition and methods of using same
11/04/2010CA2759085A1 Use of allopurinol for the treatment of hand foot skin reaction
11/04/2010CA2758738A1 Compositions and methods for treating insulin resistance and diabetes mellitus
11/04/2010CA2758596A1 Stabilized lipid formulation of apoptosis promoter
11/04/2010CA2758534A1 Lipid formulation of apoptosis promoter
11/04/2010CA2755992A1 Compressible and free-flow co-agglomerates of mannitol and granular starch
11/04/2010CA2755780A1 Use of n2o gas for treating chronic pain
11/03/2010EP2246321A1 Delayed release rasagiline formulation
11/03/2010EP2246066A1 Use of neurotoxin therapy for treatment of urologic and related disorders
11/03/2010EP2246063A1 Sustained release formulations comprising GnRH analogues
11/03/2010EP2246059A1 Adhesive patch
1 ... 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 ... 2991